SCHEMBL2484479

SCHEMBL2484479

CC(C)(C)OC(=O)CCN1CCc2ccc(C(N)=NO)cc2C1.NC(=NO)c1ccc2[nH]ncc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.39
GRIN2B Q13224 3/20 0.38
CTNNB1 P35222 3/20 0.37
WNT3A P56704 3/20 0.37
ROCK2 O75116 2/20 0.36
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36
CYP2D6 P10635 2/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 2/20 0.35
OPRK1 P41145 1/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
KMT2A Q03164 2/20 0.35
LMNA P02545 1/20 0.35
HTT P42858 1/20 0.35
GFER P55789 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL798144 0.88 ALDH1A1 (0.42) PRMT5WDR77SLC6A4OPRK1ALDH1A1
SCHEMBL771949 0.88 ALDH1A1 (0.42) PRMT5WDR77SLC6A4OPRK1ALDH1A1
SCHEMBL771948 0.88 ALDH1A1 (0.42) PRMT5WDR77SLC6A4OPRK1ALDH1A1
SCHEMBL2412606 0.84 ALDH1A1 (0.42) PRMT5WDR77SLC6A4OPRK1ALDH1A1
SCHEMBL2412605 0.84 ALDH1A1 (0.42) PRMT5WDR77SLC6A4OPRK1ALDH1A1
SCHEMBL1703624 0.81 DRD2 (0.53) CYP2D6SLC6A4ALDH1A1MAPTKMT2A
SCHEMBL12277410 0.79 NR1H2 (0.43) OPRK1ALDH1A1MAPTKMT2AKDM4E
SCHEMBL15970845 0.70 ACACB (0.41) ABCB1ROCK2PRMT5WDR77SLC6A2
SCHEMBL12277442 0.70 NR1H2 (0.67) MAPTKMT2AKDM4EMEN1
SCHEMBL2410813 0.70 NR1H2 (0.67) MAPTKMT2AKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376484-A1 OXADIAZOLE FUSED HETEROCYCLIC DERIVATIVES USEFUL FOR THE TREATMENT OF MULTIPLE SCLEROSIS Merck Serono S.A. (CH) 2011-10-19 EP disclosed
WO-2010069949-A1 OXADIAZOLE FUSED HETEROCYCLIC DERIVATIVES USEFUL FOR THE TREATMENT OF MULTIPLE SCLEROSIS MERCK SERONO S.A. (CH) 2010-06-24 WO disclosed